Tenax Therapeutics, Inc. (TENX)

1.80 -0.04 (-2.17%) USD  |  NASDAQ  |  Sep 01, 16:00
1.82 +0.02 (+1.11%) After-Hours: 06:31
More

Tenax Therapeutics Cash and Short Term Investments (Quarterly) : 117.98M for June 30, 2026

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for TENX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 117.98M
March 31, 2026 118.76M
December 31, 2025 97.56M
September 30, 2025 99.37M
June 30, 2025 105.46M
March 31, 2025 111.45M
December 31, 2024 94.85M
September 30, 2024 98.31M
June 30, 2024 9.384M
March 31, 2024 12.55M
December 31, 2023 9.792M
September 30, 2023 11.14M
June 30, 2023 13.39M
March 31, 2023 14.41M
December 31, 2022 2.124M
September 30, 2022 3.806M
June 30, 2022 7.229M
March 31, 2022 2.869M
December 31, 2021 5.584M
September 30, 2021 8.354M
June 30, 2021 2.182M
March 31, 2021 4.032M
December 31, 2020 6.713M
September 30, 2020 8.708M
June 30, 2020 4.554M
Date Value
March 31, 2020 4.857M
December 31, 2019 5.400M
September 30, 2019 7.128M
June 30, 2019 8.909M
March 31, 2019 10.82M
December 31, 2018 12.86M
September 30, 2018 4.856M
June 30, 2018 6.407M
March 31, 2018 6.618M
December 31, 2017 7.727M
September 30, 2017 8.535M
June 30, 2017 8.796M
March 31, 2017 12.52M
December 31, 2016 13.28M
September 30, 2016 7.478M
June 30, 2016 9.952M
April 30, 2016
January 31, 2016
October 31, 2015
July 31, 2015 21.31M
April 30, 2015 17.13M
January 31, 2015 17.07M
October 31, 2014 22.58M
July 31, 2014 26.12M
April 30, 2014 58.32M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Manhattan Scientifics, Inc. --
Exicure, Inc. 1.717M
Century Therapeutics, Inc. 119.71M
Absci Corp. 201.14M
Celularity, Inc. 6.175M